<DOC>
	<DOCNO>NCT00738894</DOCNO>
	<brief_summary>The primary objective determine patent foramen ovale ( PFO ) closure GORE® HELEX® Septal Occluder / GORE® Septal Occluder plus antiplatelet medical management safe effective reduces risk recurrent stroke imaging-confirmed transient ischemic attack ( TIA ) compare antiplatelet medical management alone patient PFO history cryptogenic stroke imaging-confirmed TIA .</brief_summary>
	<brief_title>GORE® HELEX® Septal Occluder / GORE® Septal Occluder Patent Foramen Ovale ( PFO ) Closure Stroke Patients - The Gore REDUCE Clinical Study</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemic Attack , Transient</mesh_term>
	<mesh_term>Foramen Ovale , Patent</mesh_term>
	<criteria>Presence cryptogenic ischemic stroke TIA presume embolic infarction verify neurologist within 180 day prior randomization Presence Patent Foramen Ovale ( PFO ) , determine initially positive bubble study utilize transesophageal echocardiography ( TEE ) , demonstrate spontaneous righttoleft shunt righttoleft shunt Valsalva maneuver . Absence identifiable source thromboembolism systemic circulation No evidence hypercoagulable state Note : Additional Inclusion Criteria may apply Other comorbidities include , limited , mural thrombus , dilate cardiomyopathy , atrial fibrillation/flutter , cardiac prosthetics ( valve ) , mitral valve stenosis , aortic dissection , significant atherosclerosis , vasculitis , preexist neurologic disorder , multiple sclerosis , arteriovenous malformation , prior intracranial hemorrhage , severe central nervous system ( CNS ) disease , severe disability relate prior stroke , autoimmune disorder would increase risk mortality morbidity typical treatment Previous Myocardial Infarction Active infection treat successfully prior randomization Sensitivity contraindication propose medical treatment Pregnancy intent become pregnant 24months randomization Indications outside parameter accept placement GORE® HELEX® Septal Occluder / GORE® Septal Occluder , include extensive congenital cardiac anomaly defect diameter estimate &gt; 18mm Atrial septal anatomy expect necessitate placement one GORE® HELEX® Septal Occluder / GORE® Septal Occluder Need concomitant procedure ( ) may confound detection adverse event related device placement Note : Additional Exclusion Criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>cryptogenic</keyword>
	<keyword>stroke</keyword>
	<keyword>transient ischemic attack</keyword>
	<keyword>TIA</keyword>
	<keyword>PFO</keyword>
	<keyword>Patent foramen ovale</keyword>
	<keyword>HELEX</keyword>
	<keyword>Septal Occluder</keyword>
	<keyword>PFO Occluder</keyword>
</DOC>